Global Tumor Ablation Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Oct 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Tumor Ablation Market By Type (Tumor Ablation Systems, Image Guidance Products, Accessories), Cancer Type (Liver Cancer, Brain Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Pancreatic Cancer, Breast Cancer, Others), Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Other Technologies), Mode of Treatment (Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation), End User (Hospitals, Oncology Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Tumor Ablation Market

Global tumor ablation market is registering a healthy CAGR of 13.80% in the forecast period of 2019-2026. This rise in the market value can be attributed to the surging usage of minimally invasive procedures due to various benefits, including less trauma, speedy recovery, and minimal complications.

Market Definition: Global Tumor Ablation Market

Tumor ablation is the technology utilized to eliminate the tumor with the help of needle, placing in the tumor organ using imaging technology. The therapy can be performed using various techniques such as microwave ablation, radiofrequency ablation, cryoablation, and other techniques. Various cancers including liver tumor, lung cancer, renal tumor, prostate cancer, and other tumors can be handled with this technology.

Market Drivers

  • The increasing incidence of cancer, is helping the market to grow
  • Rising aging population, is the major growth factors for this market
  • Technological advancements in ablation devices, are expected to grow this market
  • Various initiatives taken by the government organizations, are fueling the market growth

Market Restraints

  • Strict regulations from the government side, hinders the growth of the market
  • Delay in approval for the launch of the product, restraining the growth of the market
  • Cost containment measures by governments, is effecting the growth of the market

Segmentation: Global Tumor Ablation Market

By Type

  • Tumor Ablation Systems

    • Radiofrequency Ablation System (RFA)
    • Microwave Ablation System
    • High Intensity Focused Ultrasound
    • Laser Ablation System
    • Cryoablation

  • Image Guidance Products
  • Accessories

By Cancer Type

  • Liver Cancer
  • Brain Cancer
  • Lung Cancer
  • Bone Cancer
  • Kidney Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Others

By Technology

  • Radiofrequency (RF) Ablation 
  • Microwave Ablation
  • Cryoablation 
  • Other Technologies

By Mode of Treatment

  • Surgical Ablation
  • Laparoscopic Ablation 
  • Percutaneous Ablation

By End User

  • Hospitals
  • Oncology Clinics
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Malaysia
    • Indonesia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific

  • Middle East & Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In March 2017, Crittenton Hospital Medical Center started Tumor Ablation Program. This program is specialized in using a minimally invasive surgical procedure in any part of the body to treat cancer tumors. An ambulatory procedure, ablation is relatable to a needle biopsy, but is conducted for tumor visualization under CT scan or ultrasound guidance.
  • In January 2016, Medtronic completed the acquisition System from Baylis Medical of OsteoCool RF Ablation. After 510(k) allowance from the U.S., Medtronic introduced the cooled radiofrequency (RF) ablation tech in the U.S. approved by FDA. Medtronic and Baylis have also collaborated with the scheme to further innovate and advance technology.

Competitive Analysis:

Global tumor ablation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global tumor ablation market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in the global tumor ablation market are AngioDynamics, Boston Scientific Corporation, EDAP TMS, HealthTronics, Inc., Medtronic, Misonix, Medical Devices Business Services, Inc., Sonacare Medical, Biotronik, Inc., Erbe Elektromedizin GmbH, Smith & Nephew, CONMED Corporation, MERMAID MEDICAL A/S, Integra LifeSciences Corporation, BTG International Ltd, Abbott, BVM Medical Ltd. Limited, COMSOL INC., Cortex Technology, CooperSurgical, Inc., AtriCure, Inc.

Research Methodology: Global Tumor Ablation Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others

Reasons to Purchase this Report

  • Current and future of global tumor ablation market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

LIST OF TABLE  GLOBAL TUMOR ABLATION MARKET

TABLE 1 GLOBAL TUMOR ABLATION MARKET, BY TYPE, 2015– 2024 (USD MILLION TABLE 2 GLOBAL TUMOR ABLATION SYSTEMS MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 3 GLOBAL TUMOR ABLATION SYSTEMS MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 4 GLOBAL IMAGE GUIDANCE PRODUCT MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 5 GLOBAL ACCESSORIES MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 6 GLOBAL TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024(USD MILLION) TABLE 7 GLOBAL TUMOR ABLATION MARKET, LIVER CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 8 GLOBAL TUMOR ABLATION MARKET, BRAIN CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 9 GLOBAL TUMOR ABLATION MARKET, LUNG CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 10 GLOBAL TUMOR ABLATION MARKET, BONE CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 11 GLOBAL TUMOR ABLATION MARKET, KIDNEY CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 12 GLOBAL TUMOR ABLATION MARKET, PANCREATIC CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 13 GLOBAL TUMOR ABLATION MARKET, BREAST CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 14 GLOBAL TUMOR ABLATION MARKET,OTHERS, BY REGION, 2015 – 2024 (USD MILLION) TABLE 15 GLOBAL TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015– 2024 (USD MILLION) TABLE 16 GLOBAL SURGICAL TUMOR ABLATION MARKET, BY REGION, (2015-2024) USD MILLION TABLE 17 GLOBAL LAPAROSCOPIC TUMOR ABLATION MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 18 GLOBAL PERCUTANEOUS TUMOR ABLATION MARKET, BY REGION, 2015-2024 (USD MILLION) TABLE 19 GLOBAL TUMOR ABLATION MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 20 GLOBAL HOSPITALS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 21 GLOBAL ONCOLOGY CLINICS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 22 GLOBAL OTHERS TUMOR ABLATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 23 GLOBAL TUMOR ABLATION MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 26 NORTH AMERICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 27 NORTH AMERICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 28 NORTH AMERICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 29 EUROPE TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 30 EUROPE TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 31 EUROPE TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 32 EUROPE TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 33 EUROPE TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 34 ASIA-PACIFIC TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 35 ASIA-PACIFIC TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 36 ASIA-PACIFIC TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 37 ASIA-PACIFIC TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 38 ASIA-PACIFIC TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 39 SOUTH AMERICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 40 SOUTH AMERICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 41 SOUTH AMERICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 42 SOUTH AMERICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 43 SOUTH AMERICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 44 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 45 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 46 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY CANCER TYPE, 2015 – 2024 (USD MILLION) TABLE 47 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY MODE OF TREATMENT, 2015 – 2024 (USD MILLION) TABLE 48 MIDDLE EAST AND AFRICA TUMOR ABLATION MARKET, BY END USER, 2015 – 2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19